Efficacy News and Research

RSS
Laminin-111 protein therapy could treat Duchenne muscular dystrophy

Laminin-111 protein therapy could treat Duchenne muscular dystrophy

Spicy solution for viral infection

Spicy solution for viral infection

Final data from Symphogen's rozrolimupab Phase 2 trial on primary immune thrombocytopenia

Final data from Symphogen's rozrolimupab Phase 2 trial on primary immune thrombocytopenia

NIAID announces 14 grants for basic research to identify new HIV vaccine approaches

NIAID announces 14 grants for basic research to identify new HIV vaccine approaches

GM-CSF depletion suppresses pain in people with arthritis-related conditions

GM-CSF depletion suppresses pain in people with arthritis-related conditions

PhaseBio commences Glymera Phase 2b study in type 2 diabetes

PhaseBio commences Glymera Phase 2b study in type 2 diabetes

Vitamin D may help fight childhood acute respiratory infections

Vitamin D may help fight childhood acute respiratory infections

Tips for menopause symptom relief

Tips for menopause symptom relief

Bile duct cancer chosen as next indication for PCI Biotech

Bile duct cancer chosen as next indication for PCI Biotech

MitoTarget Project and neurodegenerative diseases: an interview with Rebecca Pruss, Ph.D., CSO of Trophos

MitoTarget Project and neurodegenerative diseases: an interview with Rebecca Pruss, Ph.D., CSO of Trophos

Medivir initiates MIV-711 phase Ib trial in healthy volunteers

Medivir initiates MIV-711 phase Ib trial in healthy volunteers

New attack on arthritis pain

New attack on arthritis pain

Encouraging results from Ocular Therapeutix's travoprost Phase II trial on glaucoma

Encouraging results from Ocular Therapeutix's travoprost Phase II trial on glaucoma

HPV genotype may alter chemoradiotherapy outcome

HPV genotype may alter chemoradiotherapy outcome

Physiotherapy beneficial for Parkinson’s patients

Physiotherapy beneficial for Parkinson’s patients

Juventas commences treatment in JVS-100 Phase II STOP-HF trial for late stage heart failure

Juventas commences treatment in JVS-100 Phase II STOP-HF trial for late stage heart failure

Lilly, Boehringer Ingelheim receive FDA approval for Tradjenta sNDA to treat type 2 diabetes

Lilly, Boehringer Ingelheim receive FDA approval for Tradjenta sNDA to treat type 2 diabetes

Curcumin shows promise in fighting devastating viruses

Curcumin shows promise in fighting devastating viruses

Preliminary results from Lexicon’s Phase 1 studies of LX2931 and LX7101 for RA

Preliminary results from Lexicon’s Phase 1 studies of LX2931 and LX7101 for RA

Be ‘medicinewise’ with cough and cold medicines in young children

Be ‘medicinewise’ with cough and cold medicines in young children

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.